Tandem Mobi insulin pump now compatible with Dexcom G7 CGM

Tandem Diabetes Care and Dexcom shared that the Tandem Mobi insulin pump with Control-IQ technology is now fully compatible with both the Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring Systems. 

Tandem Mobi, the world’s smallest, durable automated insulin delivery system, launched in the United States earlier this year.

Tandem is now the only company that offers people living with diabetes two insulin pump options that connect with both Dexcom G6 and Dexcom G7, providing more choice in how they manage their diabetes, the company said. Tandem’s #1-rated t:slim X2 insulin pump was the first AID system to feature Dexcom G7 integration, as announced in late 2023.

[Read more: Diabetes market faces disruption]

Tandem will email all Tandem Mobi users in the United States over the coming weeks, when their software update is available, with instructions on how to add the new feature free of charge by remote software update. Tandem Mobi pumps pre-loaded with the updated software are now shipping to new customers.

“Choice is a hallmark of our offerings, and we’ve proven this commitment with the expansion of our insulin pump portfolio and extended CGM compatibilities,” said John Sheridan, president and CEO of Tandem Diabetes Care. “With this integration, we’re providing more flexibility for our customers and continuing our decade-long partnership with Dexcom to bring innovative and discrete solutions to people living with diabetes.”

Tandem Mobi is small enough to be worn almost anywhere, including a coin pocket, providing users with more discretion, comfort and options for how they manage their diabetes. Powered by Control-IQ technology, which has demonstrated in real-world studies improved time in range overnight and during the day, Tandem Mobi connects with Dexcom G7 or Dexcom G6 to predict glucose levels 30 minutes in advance and automatically adjusts insulin, if needed, to help prevent highs and lows, the company said.

[Read more: How pharmacists can bridge the diabetes care education gap]

With the integration of Dexcom G7, Tandem Mobi users also can experience:

• More time in closed loop with Dexcom G7’s 30-minute sensor warm-up time—faster than any other CGM on the market.
• Additional discretion with Dexcom G7’s  all-in-one wearable.

“As the leader in connectivity, Dexcom has been the CGM of choice for the development of AID systems for over a decade,” said Jake Leach, executive vice president and chief operating officer at Dexcom. “We are proud to offer people with diabetes the ability to use Dexcom G7, our smallest and most accurate CGM, with Tandem Mobi to create a seamless user experience.”